EP, US, JP, CA pending
Leucotox starts compound modification for increased treatment efficacy in mouse models
EPO Patent Publication
LeucoTox performed first xenograft experiments with substantial treatment efficacy.
Preclinical models show efficacy of LeucoTox in myeloid leukemia in vivo.
LeucoTox submitted patent application at the European Patent Office.